Abstract
By the end of February 2021, when 48% of the Israeli population was immune, the number of new positive COVID-19 cases significantly dropped across all ages. Understanding which parameters influenced this drop and how to minimize the number of hospitalizations and overall positive cases is urgently needed.
In this study we conducted an observational analysis which included COVID-19 data with over 12,000,000 PCR tests from 250 cities in Israel. In addition, we performed a simulation of different vaccination campaigns to find the optimal policy.
Our analysis revealed that cities with younger populations reached a decrease in new cases when a lower percentage of their residents were immunized, showing that median age is a crucial parameter effecting overall immunity, while other parameters appeared to be insignificant. This variance between cities is explained by recalculating the immunized population and multiplying each individual by a factor symbolizing the impact of their age on the spread on the virus. This factor is easily calculated from historical data of positive cases per age.
The simulation proves that prioritizing different age groups or changing the rate of vaccinations drastically effects the overall hospitalizations and positive cases.
One-Sentence Summary understanding what influences reaching covid-19 overall immunity and how to maximize the effect of the vaccination campaign.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was part of the Israeli Ministry of Health virtual data-challenge event. An exemption from institutional review board approval was determined by the Israeli Ministry of Health, as part of the event. Since the event focused on creating data-driven policy tools for governmental decision makers, the data does not require legal approval of ethical boards according to the Helsinki protocols. We note, that most of the data used for this study were openly available to the public before the initiation of the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data included two main COVID-19 tables given to us by the MoH. The first with individual identification number (random number for ethical and anonymous reasons), age group, geographic region, date of polymerase chain reaction (PCR) test for identification of COVID-19 and test result, time of hospitalization, worst case while hospitalized, COVID-19 outcome (alive/dead). The second table included vaccination data, with data about the number of vaccinations per day for different ages and geographic regions. Large portions of the aggregated data used in this work is publicly available in Hebrew divided into 6 different databases. Sensitive information, mostly related to the hospitalization status is not publicly accessible. In addition to the COVID-19 data we used data from the CBS (Central Bureau of Statistics) regarding cities median age, number of people in each age group and data about families in Israel. The COVID data included 262 cities with over 5000 citizens, but only 250 were taken into account since 12 cities did not have information on their median age Our analysis code in addition to some of the publicly available data, can be found in this Git repository
